Objectives: To determine whether a novel Na+/H+ exchange ion inhibitor, zoniporide, is associated with reduced perioperative myocardial ischemic injury in high-risk surgery patients.
Design: Randomized double-blind placebo-controlled multidose trial.
Setting: Multicenter worldwide (105 centers) trial.